搜尋結果

共 2004 個結果
頁數:1...13 14 15 16 17 18 19 20 21 ...101

韓防彈少年團晤拜登 宣揚反仇亞
亮相白宮記招 傳媒逼爆31萬人看直播

... 恨犯罪法》(The COVID-19 Hate Crimes Act),以及讚揚對方致力尋找解決方法,並希望在 ...全文

今日信報EJ Global2022年06月02日

Don’t bet on a soft landing

... sponse to COVID-19 had led to lockdowns, which caused major disruptions to global supply chains and reduced the supply of workers (creating a very tight labor market in the US). Then came two addition ...More

EJ Insight2022-06-01

How will China’s currency respond to slower growth?

... tbreak of COVID-19 that has led to lockdowns. The Rise of the Chinese Dragon China’s economy began its metamorphosis into what it is today with reforms initiated by Deng Xiaoping in the 1970s and 1980 ...More

EJ Insight2022-06-01

脫歐後優勢盡失

... 民保健署NHS發出的COVID-19通行證,或者填好Spanish Travel Ministry(SpTH) ...全文

今日信報副刊文化盡付笑談毛羨寧2022年05月31日

Reducing plastic pollution at source

The fifth wave of COVID-19 epidemic in Hong Kong has been severe. In order to curb the spread of the epidemic, the government adopted stricter anti-epidemic measures, including banning dining in resta ...More

EJ Insight2022-05-30

Has the US damaged Africa’s COVID-19 vaccination drive?

The United States Food and Drug Administration’s recent decision to limit the use of the Johnson & Johnson COVID-19 vaccine to adults who cannot or will not get another vaccine will have profound ...More

EJ Insight2022-05-27

The global hunger crisis is here

... nger. The COVID-19 pandemic exposed the fragility and dysfunctionality of the world’s food systems, with movement restrictions and supply-chain disruptions driving up prices, damaging rural livelihood ...More

EJ Insight2022-05-24

開市焦點:納期今早挫1.3% 港股考驗20天線 留意車股

... 物(01877)稱,Covid-19口服藥物VV116片達到方案預設的主要終點,公 司將於近期與監管部門溝通遞 ...全文

即時新聞港股直擊2022年05月24日

君實生物(01877) (修改後標題) 公告及通告 - [內幕消息]

君實生物(01877) 內幕消息- VV116對比PAXLOVID早期治療輕中度COVID-19的III期註冊 ...全文

即時新聞港交所通告2022年05月24日

君實生物(01877) 海外監管公告-業務發展最新情況

... VID早期治療輕中度COVID-19的III期註冊臨床研究達到主要研究終點的公告(311KB, pdf) ...全文

即時新聞港交所通告2022年05月23日

君實生物(01877) 其他-業務發展最新情況

君實生物(01877) 內幕消息- VV116對比PAXLOVID早期治療輕中度COVID-19的III期註冊 ...全文

即時新聞港交所通告2022年05月23日

A bird in the hand is worth two in the bush

... st of the COVID-19 crisis, as interest rates went to zero (and in many cases below) in both nominal and real terms, the value of the bird in the hand (cash) evaporated. The hawk represents investors. ...More

EJ Insight2022-05-20

Another global recession?

... stance on COVID-19 could drive up infections and overwhelm the country’s urban hospitals. Since we have already seen the same sequence play out elsewhere – particularly in the United Kingdom, which wa ...More

EJ Insight2022-05-19

在社會邊緣的非染疫額外死亡

... gy of non–COVID-19 excess mortality and attack it with ...全文

今日信報理財投資經濟3.0曾國平2022年05月19日

Latest HK regulatory developments in the ESG space

The global economic downturn caused by the COVID-19 pandemic and unprecedented spread of wildfires across five continents have reinvigorated scrutiny from investors and consumers of ecological and soc ...More

EJ Insight2022-05-18

Fiscal capture at the ECB

... on of the COVID-19 pandemic, the fallout from Russia’s war in Ukraine, and repeated errors of judgment by the Bank of England, the US Federal Reserve, and the European Central Bank. But another possib ...More

EJ Insight2022-05-17

美國國債激增影響美元資產安全

... 達105.5%。同年COVID-19全球大流行,重創美國經濟,同時導致全球經濟衰退,第四季聯邦債務佔GDP比例 ...全文

今日信報時事評論黃伯農2022年05月17日

抗疫憤怒

... 變壞事。 大家都知道COVID-19有害,不太留意的是長期隔離抗疫所引起的心理,甚至神經問題——無論美加,都出 ...全文

今日信報副刊文化此時此刻劉健威2022年05月17日

購涵蓋新冠保障旅遊保 外遊更放心

隨着各地對COVID-19(新冠病毒)的防控措施日漸放寬,市民到外地公幹和旅遊的機會增加。然而,現時不少國家都 ...全文

今日信報理財投資通識保險許詩賢2022年05月14日

Breathing new life into medical oxygen

COVID-19 has taken at least 18 million lives, and it is anyone’s guess how many of those deaths were due to a lack of medical oxygen. Governments don’t want to talk about the issue, because that could ...More

EJ Insight2022-05-13

頁數:1...13 14 15 16 17 18 19 20 21 ...101

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。